Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2223

1.

Cancerous Protein Network That Inhibits the Tumor Suppressor Function of WW Domain-Containing Oxidoreductase (WWOX) by Aberrantly Expressed Molecules.

Saigo C, Kito Y, Takeuchi T.

Front Oncol. 2018 Aug 30;8:350. doi: 10.3389/fonc.2018.00350. eCollection 2018. Review.

2.

The Pan-Cytokeratin Staining Intensity and Fractal Computational Analysis of Breast Tumor Malignant Growth Patterns Prognosticate the Occurrence of Distant Metastasis.

Rajković N, Li X, Plataniotis KN, Kanjer K, Radulovic M, Milošević NT.

Front Oncol. 2018 Aug 30;8:348. doi: 10.3389/fonc.2018.00348. eCollection 2018.

3.

Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells.

Bahmad HF, Cheaito K, Chalhoub RM, Hadadeh O, Monzer A, Ballout F, El-Hajj A, Mukherji D, Liu YN, Daoud G, Abou-Kheir W.

Front Oncol. 2018 Aug 28;8:347. doi: 10.3389/fonc.2018.00347. eCollection 2018.

4.

WWOX Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions.

Pospiech K, Płuciennik E, Bednarek AK.

Front Oncol. 2018 Aug 28;8:345. doi: 10.3389/fonc.2018.00345. eCollection 2018. Review.

5.

Intercellular Communication in Tumor Biology: A Role for Mitochondrial Transfer.

Herst PM, Dawson RH, Berridge MV.

Front Oncol. 2018 Aug 28;8:344. doi: 10.3389/fonc.2018.00344. eCollection 2018. Review.

6.

Low-Level Laser Therapy Stimulates Proliferation in Head and Neck Squamous Cell Carcinoma Cells.

Bamps M, Dok R, Nuyts S.

Front Oncol. 2018 Aug 28;8:343. doi: 10.3389/fonc.2018.00343. eCollection 2018.

7.

Metformin as a Therapeutic Target in Endometrial Cancers.

Lee TY, Martinez-Outschoorn UE, Schilder RJ, Kim CH, Richard SD, Rosenblum NG, Johnson JM.

Front Oncol. 2018 Aug 28;8:341. doi: 10.3389/fonc.2018.00341. eCollection 2018. Review.

8.

The Mouse Hospital and Its Integration in Ultra-Precision Approaches to Cancer Care.

Clohessy JG, Pandolfi PP.

Front Oncol. 2018 Aug 28;8:340. doi: 10.3389/fonc.2018.00340. eCollection 2018.

9.

Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck.

Enokida T, Okano S, Fujisawa T, Ueda Y, Uozumi S, Tahara M.

Front Oncol. 2018 Aug 27;8:339. doi: 10.3389/fonc.2018.00339. eCollection 2018.

10.

Low-Intensity MR-Guided Focused Ultrasound Mediated Disruption of the Blood-Brain Barrier for Intracranial Metastatic Diseases.

Meng Y, Suppiah S, Surendrakumar S, Bigioni L, Lipsman N.

Front Oncol. 2018 Aug 28;8:338. doi: 10.3389/fonc.2018.00338. eCollection 2018. Review.

11.

Re-purposing Chloroquine for Glioblastoma: Potential Merits and Confounding Variables.

Weyerhäuser P, Kantelhardt SR, Kim EL.

Front Oncol. 2018 Aug 27;8:335. doi: 10.3389/fonc.2018.00335. eCollection 2018. Review.

12.

The Network of Non-coding RNAs in Cancer Drug Resistance.

Corrà F, Agnoletto C, Minotti L, Baldassari F, Volinia S.

Front Oncol. 2018 Aug 29;8:327. doi: 10.3389/fonc.2018.00327. eCollection 2018. Review.

13.

Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer.

Bisetto S, Whitaker-Menezes D, Wilski NA, Tuluc M, Curry J, Zhan T, Snyder CM, Martinez-Outschoorn UE, Philp NJ.

Front Oncol. 2018 Aug 28;8:324. doi: 10.3389/fonc.2018.00324. eCollection 2018.

14.

Immunomodulation Mediated by Anti-angiogenic Therapy Improves CD8 T Cell Immunity Against Experimental Glioma.

Malo CS, Khadka RH, Ayasoufi K, Jin F, AbouChehade JE, Hansen MJ, Iezzi R, Pavelko KD, Johnson AJ.

Front Oncol. 2018 Aug 20;8:320. doi: 10.3389/fonc.2018.00320. eCollection 2018.

15.

Applying an Exposome-Wide (ExWAS) Approach to Cancer Research.

Juarez PD, Matthews-Juarez P.

Front Oncol. 2018 Aug 27;8:313. doi: 10.3389/fonc.2018.00313. eCollection 2018.

16.

Immune Checkpoint Inhibition in Head and Neck Cancer.

Forster MD, Devlin MJ.

Front Oncol. 2018 Aug 29;8:310. doi: 10.3389/fonc.2018.00310. eCollection 2018. Review.

17.

Cell-Free DNA Profiling to Discover Mechanisms of Exceptional Response to Cabozantinib Plus Panitumumab in a Patient With Treatment Refractory Metastatic Colorectal Cancer.

Jia J, Morse MA, Nagy RJ, Lanman RB, Strickler JH.

Front Oncol. 2018 Aug 28;8:305. doi: 10.3389/fonc.2018.00305. eCollection 2018.

18.

Metabolic Plasticity of Tumor Cell Mitochondria.

Cannino G, Ciscato F, Masgras I, Sánchez-Martín C, Rasola A.

Front Oncol. 2018 Aug 24;8:333. doi: 10.3389/fonc.2018.00333. eCollection 2018. Review.

19.

Prospect of Circular RNA in Hepatocellular Carcinoma: A Novel Potential Biomarker and Therapeutic Target.

Yao R, Zou H, Liao W.

Front Oncol. 2018 Aug 23;8:332. doi: 10.3389/fonc.2018.00332. eCollection 2018. Review.

20.

Benzylamine and Thenylamine Derived Drugs Induce Apoptosis and Reduce Proliferation, Migration and Metastasis Formation in Melanoma Cells.

Mojena M, Povo-Retana A, González-Ramos S, Fernández-García V, Regadera J, Zazpe A, Artaiz I, Martín-Sanz P, Ledo F, Boscá L.

Front Oncol. 2018 Aug 23;8:328. doi: 10.3389/fonc.2018.00328. eCollection 2018.

Supplemental Content

Loading ...
Support Center